Hims & Hers Health, Inc. (HIMS)
NYSE: HIMS · Real-Time Price · USD
56.56
+4.16 (7.94%)
At close: May 30, 2025, 4:00 PM
56.80
+0.24 (0.42%)
After-hours: May 30, 2025, 7:59 PM EDT
Hims & Hers Health Stock Forecast
Stock Price Forecast
According to 12 professional analysts, the 12-month price target for Hims & Hers Health stock ranges from a low of $23 to a high of $68. The average analyst price target of $37.67 forecasts a -33.40% decrease in the stock price over the next year.
Price Target: $37.67 (-33.40%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Hims & Hers Health stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 5 | 4 | 3 | 3 |
| Buy | 1 | 1 | 0 | 0 | 0 | 0 |
| Hold | 6 | 5 | 7 | 6 | 7 | 7 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 1 | 1 | 1 | 1 | 1 |
| Total | 14 | 14 | 14 | 12 | 12 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Hold Reiterates $35 → $39 | Hold | Reiterates | $35 → $39 | -31.05% | May 6, 2025 |
| Citigroup | Citigroup | Strong Sell Maintains $25 → $30 | Strong Sell | Maintains | $25 → $30 | -46.96% | May 6, 2025 |
| Needham | Needham | Strong Buy Reiterates $61 | Strong Buy | Reiterates | $61 | +7.85% | May 6, 2025 |
| B of A Securities | B of A Securities | Sell Maintains $22 → $26 | Sell | Maintains | $22 → $26 | -54.03% | Apr 29, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $60 → $40 | Hold | Maintains | $60 → $40 | -29.28% | Apr 29, 2025 |
Financial Forecast
Revenue This Year
2.40B
from 1.48B
Increased by 62.21%
Revenue Next Year
2.90B
from 2.40B
Increased by 21.09%
EPS This Year
0.63
from 0.53
Increased by 18.82%
EPS Next Year
0.99
from 0.63
Increased by 56.94%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 2.5B | 3.2B | 4.1B | ||
| Avg | 2.4B | 2.9B | 3.5B | ||
| Low | 2.3B | 2.5B | 3.0B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 70.1% | 33.0% | 42.6% | ||
| Avg | 62.2% | 21.1% | 22.0% | ||
| Low | 52.8% | 4.3% | 5.0% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 1.02 | 1.65 | 1.92 | ||
| Avg | 0.63 | 0.99 | 1.34 | ||
| Low | 0.34 | 0.44 | 0.91 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 91.4% | 160.7% | 93.6% | ||
| Avg | 18.8% | 56.9% | 34.9% | ||
| Low | -35.6% | -30.3% | -8.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.